Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Context Therapeutics Inc. Common Stock (CNTX)

Pharmaceutical Preparations

https://www.contexttherapeutics.com

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

2001 MARKET STREET, SUITE 3915 UNIT #15
PHILADELPHIA, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/20/2021

Market Cap

193,495,614

Shares Outstanding

15,970,000

Weighted SO

15,966,053

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

TERN --.--%

TERN --.--%

AMLX --.--%

ABOS --.--%

INZY --.--%

INZY --.--%

XFOR --.--%

XFOR --.--%

SPRO --.--%

Beta

2.2960

Last Div

0.0000

Range

0.77-2.75

Chg

-0.0800

Avg Vol

261800

Mkt Cap

193495614

Exch

NASDAQ

Country

US

Phone

267 225 7416

DCF Diff

1.7550

DCF

0.9050

Div Yield

0.0000

P/S

10209.7728

EV Multiple

-4.5945

P/FV

1.4024

Div Yield %

0.0000

P/E

-7.6369

PEG

0.1146

Payout

0.0000

Current Ratio

64.0127

Quick Ratio

64.0127

Cash Ratio

63.2887

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

20680.2784

CCC

-20680.2784

Gross Margin

0.4305

Op Margin

-1056.6560

Pretax Margin

-979.6789

Net Margin

-979.6789

Eff Tax Rate

0.0156

ROA

-0.1808

ROE

-0.5312

ROCE

-0.1981

NI/EBT

1.0000

EBT/EBIT

0.9272

EBIT/Rev

-1056.6560

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-55.9019

CF/Debt

0.0000

Equity Multi

1.0159

Rec Turnover

0.0000

Pay Turnover

0.0176

Inv Turnover

0.0000

FA Turnover

1.8244

Asset Turnover

0.0002

OCF/Share

-0.3349

FCF/Share

-0.3349

Cash/Share

1.8475

OCF/Sales

-971.1075

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.4024

P/B

1.4024

P/S

10209.7728

P/E

-7.6369

P/FCF

-10.5135

P/OCF

-7.7043

P/CF

-7.7043

PEG

0.1146

P/S

10209.7728

EV Multiple

-4.5945

P/FV

1.4024

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 14, 21:58 Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76 Benzinga Dec 15, 12:46 Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Revenue Product Segmentation